New Delhi, April 14 (IANS) While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to position the country as a global leader in advanced therapeutics, experts said on Tuesday.The two-day ‘India Pharma 2026’, organised by the Department of Pharmaceuticals, in association with FICCI and IPA, New Delhi, successfully concluded here. The event witnessed part…
Latest Sudarshan Jain News & Updates
New Delhi, Feb 7 (IANS) Health industry leaders on Saturday welcomed the interim agreement on the bilateral trade deal between India and the US.As part of the interim framework, the US will slash reciprocal tariffs on Indian goods to 18 per cent. The US will also remove the reciprocal tariff on generic pharmaceuticals, among other sectors like gems and diamonds, and aircraft parts. Although full details are yet to emerge, the interim India-US trade deal framework indicates that India has receive…
New Delhi, Feb 1 (IANS) Industry experts on Sunday hailed the Union Budget 2026’s push to the biopharma sector, clinical trials, along with its thrust to the medical tourism and Ayurveda.The Union Budget 2026-27, presented by Finance Minister Nirmala Sitharaman in Parliament, proposed the Biopharma Shakti (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) scheme.The scheme, with an outlay of Rs 10,000 crores over the next five years, aims to develop India as a …
New Delhi, Jan 19 (IANS) The healthcare industry leaders and experts on Monday urged the government to significantly scale up public spending on healthcare in the forthcoming Union Budget 2026-27.The Association of Healthcare Providers – India (AHPI) noted that public health expenditure continues to remain well below the National Health Policy target of 2.5 per cent of GDP, and lags behind benchmarks seen in comparable developing economies.AHPI highlighted that India’s healthcare system is fac…